TORONTO, ONTARIO — (Marketwired) — 07/13/17 — PreveCeutical Medical Inc., the issuer resulting from a Fundamental Change of Carrara Exploration Corp. has been approved for listing.
The company also announced a share consolidation of its issued and outstanding common shares on a three (3) old to one (1) new basis. Any fraction of a share will be rounded up to the nearest whole number.
Listing and disclosure documents will be available at
PreveCeutical Medical Inc. is a biomedical company that coined the platform for preventive health sciences. PreveCeutical–s innovative research and development department advances organic and nature identical products for both prevention and curative therapies.
_______________
PreveCeutical Medical Inc., l–emetteur resultant d–un changement fondamental de Carrara Exploration Corp. a ete approuve pour inscription.
La societe a annonce une consolidation de ses actions ordinaires emises et en circulation sur 3 vieux pour 1 nouvelle base. Toute fraction d–une action sera arrondie au nombre entier le plus proche.
Les documents de divulgation et d–inscription seront disponibles a
PreveCeutical Medical Inc. est une societe bio-medicale qui a invente la plate-forme pour les sciences de la sante preventives. Le departement innovant de recherche et de developpement de PreveCeutical developpe des produits identiques a des produits organiques et naturels a la fois pour la prevention et les therapies curatives.
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:
Pour toute question, pour obtenir de l–information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l–adresse:
To unsubscribe, click .
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340